The Echo Health Ventures, Alphabet and EmblemHealth-backed care provider has secured about $500m in total, with the completion of a series C extension round.

Lilly Asia Ventures has returned to co-lead the cancer immunotherapy developer’s series C round with Greater Bay Area Homeland Investments.

The business service provider has added $40m to the round's Stripe-backed first close, doubling its valuation to $1.2bn in the process.

The workers compensation provider completed a series C round co-led by Allianz X and backed by existing investor SiriusPoint.

Orange and Deutsche Telekom Capital Partners both chipped in as the cybersecurity software provider looks to ramp up hiring.

Propel Venture Partners returned to help the employee benefits platform developer hike its total funding to more than $70m.

Globant and Mercado Libre both invested having partnered the coding education provider on a two-year programme about to launch.

The spinout of Yamaguchi University and National Cancer Centre Japan has raised the cash from investors including Dai-ichi Life and Binex.

Retinal disease drug developer Gyroscope Therapeutics has raised series C funding from investors including Fosun Pharma.

Cambridge Innovation Capital has returned for a series C round for University of Cambridge-linked Gyroscope Therapeutics, which also welcomed back Syncona.